Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

BASKING RIDGE, N.J., November 13, 2024--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) will highlight new clinical research and ...

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients ...

NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced participation in the following investor conferences in November ...

This system offers new capabilities for both clinical imaging and neuroscience with the... at 08:05 Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS ...

Qu – which, according to Parsa, is the fruit of a collaboration between a global team of experienced AI scientists, ...